|
TTBK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.238000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.894400E-02 |
| Normal-vs-Stage2 |
2.689600E-01 |
| Normal-vs-Stage3 |
2.10259999999796E-05 |
| Normal-vs-Stage4 |
6.36110000007406E-07 |
| Stage1-vs-Stage2 |
9.298000E-01 |
| Stage1-vs-Stage3 |
2.296000E-03 |
| Stage1-vs-Stage4 |
7.64390000000947E-05 |
| Stage2-vs-Stage3 |
4.106100E-02 |
| Stage2-vs-Stage4 |
1.555740E-02 |
| Stage3-vs-Stage4 |
4.309200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.135400E-03 |
| Normal-vs-AfricanAmerican |
8.39490000000831E-05 |
| Normal-vs-Asian |
7.322000E-01 |
| Caucasian-vs-AfricanAmerican |
5.280300E-02 |
| Caucasian-vs-Asian |
2.140200E-01 |
| AfricanAmerican-vs-Asian |
4.312500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.023400E-04 |
| Normal-vs-Female |
8.878300E-03 |
| Male-vs-Female |
5.273000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.788200E-04 |
| Normal-vs-Age(41-60Yrs) |
8.338200E-02 |
| Normal-vs-Age(61-80Yrs) |
8.48820000000083E-05 |
| Normal-vs-Age(81-100Yrs) |
5.730200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.064300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.015600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.546000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.330250E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.412000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.309600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.487800E-01 |
| Normal-vs-Grade 2 |
6.584400E-02 |
| Normal-vs-Grade 3 |
1.123860E-03 |
| Normal-vs-Grade 4 |
5.2271999950726E-08 |
| Grade 1-vs-Grade 2 |
2.498200E-01 |
| Grade 1-vs-Grade 3 |
7.227900E-02 |
| Grade 1-vs-Grade 4 |
8.385700E-04 |
| Grade 2-vs-Grade 3 |
1.121150E-01 |
| Grade 2-vs-Grade 4 |
3.60660000000568E-05 |
| Grade 3-vs-Grade 4 |
4.283300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.457000E-01 |
| Normal-vs-ccB subtype |
9.372200E-04 |
| ccA subtype-vs-ccB subtype |
6.138000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.666310E-02 |
| Normal-vs-N1 |
1.513230E-01 |
| N0-vs-N1 |
4.455400E-01 |
|
|
